Press Release

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market to Grow at a CAGR of 7% During 2021-2026, Driven by Growing Prevalence of ABSSS Infections

According to a new report by EMR titled, ‘Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Report and Forecast 2021-2026’, the global industry is expected to grow at a CAGR of about 7% between 2021-2026 to reach a value of around USD 14 billion by 2026.

The global industry is likely to witness robust growth in the coming years. Among the major regional markets, North America has been seen to have the highest market for the ABSSSI treatment industry, which can be attributed to the robust healthcare network as well as the complementary research facilities. The Asia Pacific and the Middle East and Africa regions can be expected to have high growth rates because of the untapped markets and high population growth rates.

GlaxoSmithKline PLC (NYSE: GSK) is a British pharmaceutical company which has been a major player in the ABSSSI treatment industry, and it has numerous other pharmaceutical products as well. As such, companies which already have a diverse range of products can utilise their contacts and supply chains of other products to promote their products in the ABSSSI treatment line.

Market Analysis by Infection Type, Route of Administration, Distribution Channel, and Region:

  • The market on the basis of infection type can be divided into hospital-acquired ABSSSI and community-acquired ABSSSI, amongst others.
  • Based on route of administration, the market can be divided into oral and parenteral.
  • The distribution channels for acute bacterial skin and skin structure infections (ABSSSI) treatment include hospital pharmacy, retail pharmacy and online, amongst others. 
  • The regional markets include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • Increasing prevalence of ABSSS infections are a major cause for the rise in demand of treatments.
  • Research into the field has brought in drugs with fewer side-effects and increased efficacy.
  • Growing awareness about the infections and the treatments are expected to open newer markets for the industry. 
  • Improving standards of healthcare and rising incomes will increase reach of medical assistance across the globe.

Key Offerings of the Report:

  • The EMR report gives an overview of the global acute bacterial skin and skin structure infections (ABSSSI) treatment market for the periods (2016-2020) and (2021-2026).
  • The report also offers the historical (2016-2020) and forecast (2021-2026) markets for the infection type, route of administration, distribution channel and regions of acute bacterial skin and skin structure infections (ABSSSI) treatment market. 
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global acute bacterial skin and skin structure infections (ABSSSI) treatment market are Debiopharm Internation SA, Melinta Therapeutics, Inc., Paratek Pharmaceuticals, Inc., and GlaxoSmithKline PLC, amongst others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.